{"id":3217,"date":"2015-05-03T07:30:42","date_gmt":"2015-05-03T07:30:42","guid":{"rendered":"http:\/\/biomedpharmajournal.org\/?p=3217"},"modified":"2016-09-29T06:16:05","modified_gmt":"2016-09-29T06:16:05","slug":"assessment-of-factors-associated-with-readmission-of-patients-with-chronic-obstructive-pulmonary-disease-in-internal-department-of-hospitals","status":"publish","type":"post","link":"https:\/\/biomedpharmajournal.org\/staging\/vol7no2\/assessment-of-factors-associated-with-readmission-of-patients-with-chronic-obstructive-pulmonary-disease-in-internal-department-of-hospitals\/","title":{"rendered":"Assessment of Factors Associated with Readmission of Patients with Chronic Obstructive Pulmonary Disease in Internal Department of Hospitals"},"content":{"rendered":"

Introduction<\/strong><\/p>\n

Chronic obstructive pulmonary disease is the most common cause of disability and death resulted from pulmonary diseases, which is associated with chronic obstruction of airflow into or out of the lungs. This obstruction is a kind of diffuse obstruction in the airways, which increases resistance to airflow. Diseases such as chronic bronchitis, bronchiectasis and emphysema are included in chronic obstructive pulmonary diseases (1). World Health Organization has defined chronic obstructive pulmonary disease as a disease characterized by airflow limitation in airways and not fully reversible (2). More than 16 million people are suffered by the disease in USA, where it is the fourth leading cause of death. Excessive secretion of mucus in the airways without regard to a specific cause (bronchitis or bronchiectasis), increase in the size of inferior airways in comparison with terminal bronchioles, destruction of alveolar walls and destruction of lung accumulation property after dilation and constriction of airways with varied intensity can be seen in patients with chronic obstructive pulmonary disease, disturbing airway dynamics, narrowing them and removing their elasticity property (3). In most cases, there is a combination of above cases in patient. The Symptoms begin in middle ages and increase with age. Although some functions of lungs, such as vital capacity and expiratory volume, decrease with age, the disease causes many of these changes to be intensified, airways to be blocked (as bronchitis) and lung elasticity to be impaired (as emphysema) (4). According to information obtained from the Institute of Health Services of the Ministry of Health, 73,000 people have been diagnosed with chronic obstructive lung disease in Columbia with 4.3% of people over 45 years.\u00a0 Of course, based on a study to estimate the costs of chronic obstructive pulmonary disease among patients with mild to severe in Vancouver, Canada, the actual prevalence rate is about 8.4% of people over 40 years (5). Since one of the important goals in healthcare system is to reduce costs to patients and healthcare system, therefore to achieve the goals, patients must have a minimum length of stay and the number of admissions must be minimized. So, the researchers sought to conduct a survey in this field in order to provide effective remedies to reduce the number of these patients\u2019 hospitalization and study related factors. For this reason, they performed a study entitled \u201cAssessment of Factors Associated with Readmission of Patients with Chronic Obstructive Pulmonary Disease in Internal Department of Hospitals in Zanjan\u201d.<\/p>\n

Methods<\/strong><\/p>\n

The study was conducted as correlational descriptive survey on 230 patients with chronic obstructive pulmonary disease in internal department of hospitals in Zanjan. Sampling was an available, objective – based sampling. Data was obtained through a researcher \u2013 made questionnaire. Test – retest method and content validity method were used to determine the reliability and validity of the questionnaire, respectively. In this case, the questionnaires were filled by ten patients with chronic obstructive pulmonary disease and then, questionnaires were reassessed with interval of two weeks and responses were determined using correlation statistical test and then confirmed with correlation coefficient more than 0.89%.<\/p>\n

Results<\/strong><\/p>\n

The sample consisted of 143 (62.5%) males and 88 (38.5%) females. 8.5% of subjects were aged 30-49 years and 89.5% over 50 years, and their mean age was 65.7 years. 72.6% were married, 0.5% single, 0.9% divorced and23.9% widowed.\u00a0 67.8% were illiterate, 20.7% had primary education, 5.2% middle school education, 2.1% high school education, and the rest university education. 31.2% were house-keeper that is related to female research units, 6.4% laborer, 3% farmer, 2.6% employee, 9.4% unemployed, 24.4% retired, 12.4 self-employed and the rest had the other jobs. 48% of research units had disease severity class II, 31% class III and 18% class IV. \u00a0The disease was diagnosed in patients aged 18-37 years in 3% of cases,\u00a0 35-45 years in 14.5%, 46-55 years \u00a0in 31.2%, 56-65 years in 26.9%, 66-75 years \u00a0in 14.1%, and over 75 years in the rest of cases.\u00a0 62.5% of patients had a history of smoking, and 37.5% did not. The mean duration of smoking was 25.4 years, 17.9% of subjects were smoking 5-1 cigarettes a day and the rest 11-15 cigarettes a day.\u00a0 39.3% had been hospitalized twice and the rest more than three times. 12.8% were under medical treatment less than three years, 29.5% 4-6 years and the rest more than 10 years. The results show that there is a significant relationship between associated factors and readmission in patients with chronic obstructive pulmonary disease.<\/p>\n

Discussion<\/strong><\/p>\n

Chronic obstructive pulmonary disease includes chronic bronchitis and emphysema. Chronic bronchitis is expressed as difficulty in breathing due to persistent inflammation and thickening of airway. Risk factors for the disease are environmental and genetic factors, that both smoking and passive smoking are the cause of 80-90% of these patients. Other factors include occupational issues, environmental pollution and genetic disorders, such as alpha-antitrypsin deficiency which normally prevents the destruction of lung tissue by other enzymes (6). Since taking care of chronic obstructive pulmonary disease is one of the key aspects of the disease process and nursing, it is essential to address the disease due to its cost in this aspect. Therefore, educating patients and families can improve the quality of life and coping skills and reduce the risk of hospitalization in these patients (7). And an approach based on self-management regarding the disease by professionals can significantly improve their health and reduce readmission or exacerbation by 40%. Readmission is more important today than ever before, because healthcare costs are rapidly raising and advances occurred in software and hardware technology have made it easier to examine and seek readmission and more information is available. Readmission rate is an important criterion in evaluating the quality of healthcare and is considered as a key measurement tool to examine the results of healthcare (8). The results of a study conducted by Elikharz et al. (2011) in connection with data obtained from hospitalized patients with chronic obstructive pulmonary disease in 15 states of America are somewhat similar and compatible with the results of the present study (9). MC Guan et al. (2007) conducted a study on qualified patients discharged from hospital after a period of chronic lung disease exacerbation in 2003-2007, that factors related to readmission are almost the same as the current study (10). In another study done by Chan et al. in 2006-2007 in Hong Kong on patients with chronic obstructive pulmonary disease and unplanned readmission showed that this study was similar to the aforementioned study and there is a significant relationship between unplanned readmissions and\u00a0 individual and lifestyle factors and nursing and healthcare services (11). The findings of a correlational descriptive study by Bathaiea in 2008 entitled \u201cassessment of relevant factors and readmission of patients with heart failure in hospitals of Shahid Beheshti University of Medical Sciences\u201d are also consistent with the findings of our study (12).<\/p>\n

Conclusion<\/strong><\/p>\n

Assessment and control of factors affecting patient readmissions, including clinical and functional status, medical care and medication, the desire to take medicine, lifestyle and personal factors, matter in different aspects, whether \u00a0in reducing costs imposed on the health care system and patients, or\u00a0 increase in patients\u2019\u00a0 quality of life and decrease in subsequent difficulties of frequent admissions. It also reduces the workload of nurses, who are involved in taking care of patients directly and at highest level.\u00a0 Some factors are not controlled, but others like knowledge of patients, control of co-existing diseases, control of risk factors such as not smoking and offering information needed and appropriate for patient status can be effective in readmission rate reduction.<\/p>\n

References\u00a0<\/strong><\/p>\n

    \n
  1. 1. Samim P . Medical Surgical Nursing Brunner Sudars respiratory diseases , First Edition , Tehran Boshra Publications . 2008.<\/li>\n
  2. World health organization. (2006), therapeutic education of patients with copd :training guide for General practitioners pI.111.<\/li>\n
  3. Begrin G , Textbook of Internal Medicine , Washington ,Internal Medicine ” Translation by Ghodsi R , Second edition ,Teymorzade Publications . 2004.<\/li>\n
  4. Harrison Hall. (2008) ,Flarisson Principle\u00a0 of internal Medicine,Denice Kaspier,\u00a0 vol(11) sixteen the Edition , Mc. Graw \u2013 Hill .Co<\/li>\n
  5. Smeltzer Sc & Bare BG.(2008) , Brunner & Suddarths text book of Medical surgical nursing 11th ed,Philadelphia, lippincatt Williams & wilkins .<\/li>\n
  6. Ros E , Medical Surgical Nursing Brunner Sudars respiratory diseases , Translation by Asadi AA , Tehran , Salemi Publications 2008.<\/li>\n
  7. Cecil. (2008), text book\u00a0\u00a0 Medicine of Essentials, Thomas\u00a0 Andreoli, M.d & etal fifth Edition.<\/li>\n
  8. Andorli T , Principles of Internal Medicine, Sicily , Translation by Azizian , Tehran , Rafi Publications , 2007.<\/li>\n
  9. Elikharz & etall (2011) ,Epidemiology\u00a0 and management of COPD in British Columbia. Canada Respiratory journal (15),22-417.<\/li>\n
  10. MC Guan R, etal (2007).predictors of readmission and death after sever exacerbation of\u00a0 COPD .chest .132 (6) 1748-1755.<\/li>\n
  11. Chan F &etal\u00a0 \u00a0.Risk factors\u00a0 of hospitalization and readmission with COPD in Hong Kong population :Analysis of hospital admission record .BMC health services Research . (2007)<\/li>\n
  12. Bathaiea S , assessment of relevant factors and readmission of patients with heart failure in hospitals of Shahid Beheshti University of Medical Sciences , Thesis for a master’s degree in nursing , 2008.<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

    Introduction Chronic obstructive pulmonary disease is the most common cause […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[19],"tags":[],"class_list":["post-3217","post","type-post","status-publish","format-standard","hentry","category-vol7no2"],"_links":{"self":[{"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/posts\/3217","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/comments?post=3217"}],"version-history":[{"count":6,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/posts\/3217\/revisions"}],"predecessor-version":[{"id":8863,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/posts\/3217\/revisions\/8863"}],"wp:attachment":[{"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/media?parent=3217"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/categories?post=3217"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/tags?post=3217"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}